A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans a ...

Type 2 diabetes is a leading cause of chronic kidney disease, which affects more than 1 in 7 U.S. adults. The new approval ...

Hims & Hers may leverage FDA compounding exemptions to further extend its compounded GLP-1 offerings. Learn why HIMS stock is ...

The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

Research suggests caffeine can help with weight loss, but a large dose is necessary to create a response. A 2020 review in ...

Scarlett Johansson’s trainer Eric Johnson stops by Studio 1A to help a TODAY viewer accomplish her fitness goals for 2025. He ...

The company emphasised that it is ready to meet the growing demand for drug-device combinations and biologics, with ...

Health Canada has issued a recall notice for compounded drugs containing semaglutide, which is a key component in popular medications like Ozempic and Wegovy.

Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market.

A Georgia woman who lost 60 pounds taking semaglutide spent nearly $20,000 on a 'mommy makeover' only to pile the weight back ...

Lexaria Bioscience Corp., a global innovator in drug delivery platforms, has announced partial final results showcasing the ...